Strides Arcolab has reported results for third quarter ended September 30, 2012.
On standalone basis, the company reported net profit at Rs 30.11 crore for third quarter ended September 30, 2012 as compared to net loss of Rs 65.19 crore for the same quarter in the previous year. However, total income registered growth of 0.44% to Rs 198.49 crore for quarter under review as compared to Rs 197.62 crore for the quarter ended September 30, 2011.
On consolidated basis, group reported 12.95% growth in its net profit at Rs 52.49 crore for quarter as compared to net profit of Rs 46.47 crore for the same quarter in the previous year. However, total income decreased by 22.71% to Rs 602.99 crore for quarter under review as compared to Rs 780.15 crore for the quarter ended September 30, 2011
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
